Published in Naunyn Schmiedebergs Arch Pharmacol on December 01, 1988
Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures. Acta Neuropathol (1994) 1.01
In vivo long-term synaptic plasticity of glial cells. J Physiol (2010) 0.80
Pyrimidine nucleotide-stimulated thromboxane A2 release from cultured glia. Cell Mol Neurobiol (1998) 0.75
Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol (1977) 2.10
Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. J Neurosci (1989) 1.22
Influence of angiotensin, vasopressin or changes in flow rate on vasoconstriction, changes in volume and [3H]-noradrenaline release following postganglionic sympathetic nerve stimulation in the isolated cat spleen. Br J Pharmacol Chemother (1966) 1.20
Synthesis and release of prostaglandins by rat brain synaptosomal fractions. J Neurochem (1976) 1.17
Influence of isoproterenol, hydralazine and phentolamine on the renin activity of plasma and renal cortex of rats. Eur J Pharmacol (1970) 1.14
The importance of endogenous prostaglandins other than prostacyclin, for the modulation of contractility of some rabbit blood vessels. Br J Pharmacol (1984) 1.14
Protean agonism at alpha2A-adrenoceptors. Mol Pharmacol (1998) 1.08
Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302. Br J Pharmacol (2007) 1.04
Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation. Neuroscience (1997) 1.02
Co-release of noradrenaline and ATP from cultured sympathetic neurons. Neuroscience (1994) 1.01
Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.01
Protein kinase C activation and alpha 2-autoreceptor-modulated release of noradrenaline. Br J Pharmacol (1987) 1.01
Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.00
[Explant test with skin and peritoneum of the neonatal rat as a predictive test of tolerance of local anti-infective agents in wounds and body cavities]. Chirurg (1998) 0.99
The role of endothelial and non-endothelial prostaglandins in the relaxation of isolated blood vessels of the rabbit induced by acetylcholine and bradykinin. Br J Pharmacol (1986) 0.97
Potentiation and abolition of the increase in plasma renin activity seen after hypotensive drugs in rats. Eur J Pharmacol (1972) 0.96
The mechanism of the drinking response to some hypotensive drugs: activation of the renin-angiotensin system by direct or reflex-mediated stimulation of -receptors. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.96
Release of prostaglandins from isolated cat spleen by angiotensin and vasopressin. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.95
Islet-activating protein (pertussis toxin) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.95
Effects of intracerebroventricular administration of prostaglandin D2 on behaviour, blood pressure and body temperature as compared to prostaglandins E2 and F2 alpha. Psychopharmacology (Berl) (1983) 0.94
Effect of prostaglandins D2, E2 and F2alpha on catecholamine release from slices of rat and rabbit brain. Eur J Pharmacol (1981) 0.94
Polymyxin B, a selective inhibitor of protein kinase C, diminishes the release of noradrenaline and the enhancement of release caused by phorbol 12,13-butyrate. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.94
Adenosine: an endogenous modulator of hippocampal noradrenaline release. Neuropharmacology (1985) 0.91
Enhancement of noradrenaline release by 12-O-tetradecanoyl phorbol-13-acetate, an activator of protein kinase C. Eur J Pharmacol (1986) 0.91
Alpha2-adrenoceptor agonists stimulate high-affinity GTPase activity in a receptor subtype-selective manner. Eur J Pharmacol (1999) 0.91
Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine. Mol Pharmacol (2001) 0.91
Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.91
Are cerebral prostanoids of astroglial origin? Studies on the prostanoid forming system in developing rat brain and primary cultures of rat astrocytes. Brain Res (1987) 0.91
Modulation of hippocampal serotonin (5-HT) release by endogenous adenosine. Eur J Pharmacol (1985) 0.90
Human kisspeptins activate neuropeptide FF2 receptor. Neuroscience (2010) 0.90
Regulation and glucocorticoid-independent induction of lipocortin I in cultured astrocytes. J Neurochem (1991) 0.88
Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release. Eur J Pharmacol (1988) 0.88
[Inhibition by nephrectomy of drinking induced by hypotensive agents in rats]. Experientia (1971) 0.88
Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasma. Eur J Pharmacol (1981) 0.87
The adenosine receptor-mediated inhibition of noradrenaline release possibly involves an N-protein and is increased by alpha 2-autoreceptor blockade. Br J Pharmacol (1987) 0.87
Protein kinase C and presynaptic modulation of acetylcholine release in rabbit hippocampus. Br J Pharmacol (1988) 0.86
Endogenous noradrenaline impairs the prostaglandin-induced inhibition of noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.86
Role of vasopressin in the ACTH response to isoprenaline. Eur J Pharmacol (1982) 0.86
[Effect of various blood pressure-lowering drugs on water uptake and output in rats]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.86
Effect of pretreatment with 6-hydroxydopamine on the uptake and metabolism of catecholamines by the isolated perfused rat heart. Br J Pharmacol (1971) 0.85
Comparison of the prostanoid synthesizing capacity in homogenates from primary neuronal and astroglial cell cultures. Biochem Pharmacol (1984) 0.84
[Pharmacokinetic studies on 3H-hexoprenaline in the rat]. Arzneimittelforschung (1973) 0.84
Presynaptic kappa-opioid receptors on noradrenergic nerve terminals couple to G proteins and interact with the alpha 2-adrenoceptors. J Neurochem (1989) 0.84
False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine. Br J Pharmacol (1986) 0.84
Inhibition of central neurotransmitter release by omega-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.84
Rat microglial interleukin-3. J Neuroimmunol (1994) 0.84
On the relation between contraction and prostaglandin release in rabbit mesenteric blood vessels. Eur J Pharmacol (1980) 0.84
The importance of Ca2+-mediated phospholipase A2 activation for stimulus-evoked PGE2-release from rabbit splenic capsular strips. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.84
Uptake kinetics and metabolism of 7-3H-dopamine in the isolated perfused rat heart. Br J Pharmacol (1971) 0.84
N-ethylmaleimide (NEM) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.84
Regional distribution of arachidonic acid metabolites in rat brain following convulsive stimuli. Prostaglandins (1981) 0.83
Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.83
Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor. Endocrinology (1984) 0.83
Role of dopamine receptors in the modulation of acetylcholine release in the rabbit hippocampus. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.83
Different apparent modes of inhibition of alpha2A-adrenoceptor by alpha2-adrenoceptor antagonists. Eur J Pharmacol (1997) 0.83
Evidence for the involvement of a GABA-mediated inhibition in the hypovolaemia-induced vasopressin release. Pflugers Arch (1980) 0.83
Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT)-release. Dual effects of yohimbine, rauwolscine and corynanthine as alpha-adrenoceptor antagonists and 5-HT-receptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.83
3,4-Diaminopyridine-induced noradrenaline release from CNS tissue as a model for action potential-evoked transmitter release: effects of phorbol ester. Eur J Pharmacol (1989) 0.82
Differences in the mode of stimulation of cultured rat sympathetic neurons between ATP and UDP. Neuroscience (1997) 0.82
A detailed study on the effects of protein kinase C activation on alpha-2 adrenoceptor-coupled modulation of norepinephrine release in hippocampus. J Pharmacol Exp Ther (1991) 0.82
Phorbol ester-mediated enhancement of hippocampal noradrenaline release: which ion channels are involved? Eur J Pharmacol (1988) 0.82
Influence of serotonin on water intake and the renin-angiotensin system in the rat. Arch Int Pharmacodyn Ther (1974) 0.81
Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents. Br J Pharmacol (2006) 0.81
Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.81
P2 purinoceptors modulating noradrenaline release from sympathetic neurons in culture. Eur J Pharmacol (1994) 0.81
Vasopressin and beta-endorphin release after osmotic and non-osmotic stimuli: effect of naloxone and dexamethasone. Eur J Pharmacol (1982) 0.81
Evidence for inhibition by beta-endorphin of vasopressin release during foot shock-induced stress in the rat. Neuroendocrinology (1982) 0.81
Naloxone promotes stimulus-evoked vasopressin release in vivo. Eur J Pharmacol (1980) 0.81
Possible involvement of protein kinase C (PKC) in the regulation of electrically evoked serotonin (5-HT) release from rabbit hippocampal slices. Eur J Pharmacol (1987) 0.81
Potential anticonvulsive properties of endogenous prostaglandins formed in mouse brain. Brain Res (1982) 0.81
Lesions of supracallosal or infracallosal hippocampal pathways in the rat: behavioral, neurochemical, and histochemical effects. Behav Neural Biol (1994) 0.80
Increased prostaglandin formation in rat brain following systemic application of kainic acid. Brain Res (1987) 0.80
Identification of mechanisms involved in the modulation of release of noradrenaline in the hippocampus of the rabbit in vitro. Neuropharmacology (1984) 0.80
Staurosporine counteracts the phorbol ester-induced enhancement of neurotransmitter release in hippocampus. Arch Int Pharmacodyn Ther (1989) 0.80
Studies on the interaction between presynaptic alpha 2-adrenoceptors and adenosine A1 receptors located on noradrenergic nerve terminals. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.80
alpha-Adrenoceptor-mediated inhibitory effect of the sympathetic nervous system on the isoprenaline-induced increase in plasma renin concentration. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.79
[On the mechanism of potentiation of catecholamine action following chronic postganglionic sympathetic denervation]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.79
Effect of hydrazinophthalazines on catecholamines in rats. Eur J Pharmacol (1969) 0.79
Effect of extracellular dopamine on the release of dopamine in the rabbit caudate nucleus: evidence for a dopaminergic feedback inhibition. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.79
Regulatory proteins in presynaptic function. Ann N Y Acad Sci (1990) 0.79
Characterization of cysteinyl-leukotriene formation in primary astroglial cell cultures. J Pharm Pharmacol (1990) 0.79
On the relation between release of prostaglandins and contractility of rabbit splenic capsular strips. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.79
Presynaptic alpha 2-adrenoceptors inhibit calcium influx in terminals of chicken sympathetic neurons and noradrenaline release evoked by nicotinic stimulation. Neurosci Lett (1994) 0.79
Synaptosomal calcium uptake systems: prostaglandins are probably not involved in the regulation of calcium fluxes into and within the nerve endings. J Neurochem (1982) 0.79
The stable prostacyclin-analogue, iloprost, unlike prostanoids and leukotrienes, potently stimulates cyclic adenosine monophosphate synthesis of primary astroglial cell cultures. J Pharm Pharmacol (1988) 0.78
Vasopressin stimulates release of beta-lipotropin and beta-endorphin in conscious rats as measured by radioimmunoassay of unextracted plasma. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.78
[Kinetics of the uptake and transformation of 7-3H-dopamine in the isolated perfused rat heart]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.78
Effect of K+ channel blockers on the alpha 2-adrenoceptor-coupled regulation of electrically evoked noradrenaline release in hippocampus. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.78
An in vitro model of 1-methyl-4-phenyl-pyridinium (MPP+) toxicity: incubation of rabbit caudate nucleus slices with MPP+ followed by biochemical and functional analysis. Br J Pharmacol (1988) 0.78
No evidence for presynaptic opioid receptors on cholinergic, but presence of kappa-receptors on dopaminergic neurons in the rabbit caudate nucleus: involvement of endogenous opioids. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.78
Characterization of seizure-induced cysteinyl-leukotriene formation in brain tissue of convulsion-prone gerbils. J Neurochem (1988) 0.78
Lowering of the convulsive threshold by non-steroidal anti-inflammatory drugs. Eur J Pharmacol (1981) 0.78
Effect of converting enzyme blockade on isoprenaline- and angiotensin I-induced drinking. Br J Pharmacol (1974) 0.78
Alpha 2-adrenoceptor mediated inhibition of exocytotic noradrenaline release in the absence of extracellular Ca2+. Eur J Pharmacol (1992) 0.78
Radioligand binding studies with 3-(4-(2-hydroxy-3-((1, 1-dimethylethyl)-amino)-propoxy)-phenyl)-7-methoxy-2-methyl- 1(2H)-isoquinolinone (HI-42), a new cardioselective beta-adrenoceptor blocker with long-lasting effects in vivo. Arzneimittelforschung (1985) 0.78